强生三季度业绩超出预期，并上调了全年调整后每股收益指引。周二盘前交易中，JNJ股价下跌1.4%，此前业绩基本符合预期。中东冲突拖累了本季度强生医疗器械的销售。来源J&J beats earnings estimates; Middle East conflict weighs on medical device salesReutersJ&J falls premarket despite raised earnings guidanceSeekingalpha
